Table 2.

Implantation and performance information

Subject	Implant type	Strategy	Cochleostomy, mm	DI mm	IL mm	CDL mm	IL/AEL	IL/CDL	DI/AEL	DI/CDL	NU-6 %
1	Clarion	CIS	3	21.0	18.0	29.5	1.20	0.61	1.40	0.71	48
2	Nucleus 22	unknown	1.5	20.2	18.7	28.5	1.19	0.66	1.28	0.71	01
3	Nucleus 22	SPEAK	4.5	22.5	18.0	34.3	1.14	0.52	1.43	0.66	10
4	Nucleus 22	MPEAK	1.7	19.5	17.8	30.0	1.13	0.59	1.24	0.65	30
5	Nucleus 24R	ACE	4.5	23.2	18.7	33.0	1.59	0.57	1.98	0.70	8
6	Nucleus 22	SPEAK	4.5	21.0	16.5	31.6	1.05	0.52	1.33	0.66	16
7	Ineraid	CA	3	24.0	21.0	31.0	1.05	0.68	1.20	0.77	2
8	Nucleus 22	SPEAK	4.8	20.8	16.0	33.2	1.02	0.48	1.32	0.63	34
9	Nucleus 22	SPEAK	4	19.8	15.8	32.8	1.00	0.48	1.26	0.60	26
10	Nucleus 24M	SPEAK	5	22.0	17.0	25.5	1.08	0.67	1.40	0.86	58
11	Ineraid	CIS	4	23.0	19.0	33.9	0.95	0.56	1.15	0.68	16
12	Nucleus 22	SPEAK	3.4	18.2	14.8	28.9	0.94	0.51	1.16	0.63	4
13	Nucleus 22	SPEAK	4	20.0	16.0	33.4	1.02	0.48	1.27	0.60	40
14	Nucleus 24M	SPEAK	4.8	18.5	13.7	26.1	0.87	0.52	1.18	0.71	24
15	Ineraid	CIS	3.8	21.3	17.5	34.0	0.88	0.51	1.07	0.63	22
16	Ineraid	CIS	5	22.3	17.5	32.8	0.88	0.53	1.12	0.68	90
17	Nucleus 22	MPEAK	5	18.0	13.0	28.1	0.83	0.46	1.14	0.64	10
18	Nucleus 22	unknown	3.5	16.2	12.7	28.0	0.81	0.45	1.03	0.58	56
19	Ineraid	CIS	6.8	22.8	16.0	30.4	0.80	0.53	1.14	0.75	70
20	Nucleus 24M	SPEAK	3.3	16.7	13.4	30.7	0.85	0.44	1.06	0.54	6
21	Nucleus 22	SPEAK	4	16.0	12.0	30.8	0.76	0.39	1.02	0.52	12
22	Nucleus 22	F0/F1/F2	3	15.0	12.0	28.4	0.76	0.42	0.95	0.53	14
23	Nucleus 24M	CIS	3.5	15.8	12.3	30.9	0.78	0.40	1.00	0.51	58
24	Ineraid	CA	1	14.5	13.5	28.8	0.68	0.47	0.73	0.50	6
25	Nucleus 22	SPEAK	3	12.0	9.0	32.6	0.57	0.28	0.76	0.37	30
26	Nucleus 22	MPEAK	4	11.9	7.9	35.1	0.50	0.23	0.76	0.34	181
27	Clarion	CIS	0	9.0	9.0	29.0	0.60	0.31	0.60	0.31	111
		maximum	6.8	24.0	21.0	35.1	1.20	0.68	1.47	0.86	90
		minimum	0.0	9.0	7.9	25.5	0.50	0.23	0.60	0.31	0
		mean	3.7	18.7	15.1	30.8	0.91	0.49	1.13	0.61	26.6

NU-6 = Percentage word score for the last recorded NU-6 word test.

¹Word score estimated by the method of Rabinowitz et al. [1992],